{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T23:17:22Z","timestamp":1788995842128,"version":"build-2803163510"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T00:00:00Z","timestamp":1754092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T00:00:00Z","timestamp":1754092800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Clinical Medical Research Center for Cardiovascular Diseases","award":["NCRC2020015"],"award-info":[{"award-number":["NCRC2020015"]}]},{"name":"High-Level Hospital Clinical Research Funding","award":["2022-GSP-GG-26"],"award-info":[{"award-number":["2022-GSP-GG-26"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-025-05042-7","type":"journal-article","created":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T05:54:44Z","timestamp":1754114084000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The impact of atrial fibrillation type on clinical outcomes and antithrombotic therapy at discharge in patients with acute coronary syndrome or undergoing percutaneous coronary intervention: a real-world study"],"prefix":"10.1186","volume":"25","author":[{"given":"Yimeng","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyuan","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijing","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanmin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,2]]},"reference":[{"issue":"3","key":"5042_CR1","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1111\/jce.15351","volume":"33","author":"JJ Noubiap","year":"2022","unstructured":"Noubiap JJ, Agbaedeng TA, Nyaga UF, et al. Atrial fibrillation incidence, prevalence, predictors, and adverse outcomes in acute coronary syndromes: a pooled analysis of data from 8 million patients [J]. J Cardiovasc Electrophysiol. 2022;33(3):414\u201322.","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"16","key":"5042_CR2","doi-asserted-by":"publisher","first-page":"961","DOI":"10.4244\/EIJ-E-24-00043","volume":"20","author":"T Potpara","year":"2024","unstructured":"Potpara T. Atrial fibrillation and acute coronary syndrome [J]. EuroIntervention. 2024;20(16):961\u20133.","journal-title":"EuroIntervention"},{"key":"5042_CR3","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.amjcard.2021.11.043","volume":"167","author":"P Gouda","year":"2022","unstructured":"Gouda P, Dover DC, Savu A, et al. Long-term outcomes for patients with acute coronary syndrome and nonvalvular atrial fibrillation [J]. Am J Cardiol. 2022;167:54\u201361.","journal-title":"Am J Cardiol"},{"issue":"12","key":"5042_CR4","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1002\/clc.23463","volume":"43","author":"C Blomstrom-Lundqvist","year":"2020","unstructured":"Blomstrom-Lundqvist C, Marrouche N, Connolly S, et al. Efficacy and safety of dronedarone by atrial fibrillation history duration: insights from the ATHENA study [J]. Clin Cardiol. 2020;43(12):1469\u201377.","journal-title":"Clin Cardiol"},{"issue":"5","key":"5042_CR5","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.122.011585","volume":"16","author":"J Dickow","year":"2023","unstructured":"Dickow J, Kany S, Roth Cardoso V, et al. Outcomes of early rhythm control therapy in patients with atrial fibrillation and a high comorbidity burden in large real-world cohorts [J]. Circ Arrhythm Electrophysiol. 2023;16(5): e011585.","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"2","key":"5042_CR6","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1177\/2396987319896674","volume":"5","author":"A Mentel","year":"2020","unstructured":"Mentel A, Quinn TJ, Cameron AC, et al. The impact of atrial fibrillation type on the risks of thromboembolic recurrence, mortality and major haemorrhage in patients with previous stroke: a systematic review and meta-analysis of observational studies [J]. Eur Stroke J. 2020;5(2):155\u201368.","journal-title":"Eur Stroke J"},{"issue":"6","key":"5042_CR7","doi-asserted-by":"publisher","first-page":"euad143","DOI":"10.1093\/europace\/euad143","volume":"25","author":"G Ntaios","year":"2023","unstructured":"Ntaios G, Sagris D, Buckley BJR, et al. Risk of myocardial infarction and ischemic stroke in individuals with first-diagnosed paroxysmal vs. non-paroxysmal atrial fibrillation under anticoagulation [J]. Europace. 2023;25(6):euad143.","journal-title":"Europace"},{"issue":"5","key":"5042_CR8","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1093\/europace\/euv390","volume":"18","author":"G Boriani","year":"2016","unstructured":"Boriani G, Laroche C, Diemberger I, et al. \u2018Real-world\u2019 management and outcomes of patients with paroxysmal vs non-paroxysmal atrial fibrillation in Europe: the EURObservational Research Programme-Atrial Fibrillation (EORP-AF) general pilot registry [J]. Europace. 2016;18(5):648\u201357.","journal-title":"Europace"},{"issue":"4","key":"5042_CR9","first-page":"527","volume":"13","author":"L Manzi","year":"2024","unstructured":"Manzi L, Florimonte D, Forzano I, et al. Antiplatelet therapy in patients requiring oral anticoagulation and undergoing percutaneous coronary intervention [J]. Interv Cardiol Clin. 2024;13(4):527\u201341.","journal-title":"Interv Cardiol Clin"},{"issue":"36","key":"5042_CR10","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","volume":"45","author":"IC Van Gelder","year":"2024","unstructured":"Van Gelder IC, Rienstra M, Bunting KV, et al. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) [J]. Eur Heart J. 2024;45(36):3314\u2013414.","journal-title":"Eur Heart J"},{"issue":"23","key":"5042_CR11","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1093\/eurheartj\/ehu063","volume":"35","author":"A Narula","year":"2014","unstructured":"Narula A, Mehran R, Weisz G, et al. Contrast-induced acute kidney injury after primary percutaneous coronary intervention: results from the HORIZONS-AMI substudy [J]. Eur Heart J. 2014;35(23):1533\u201340.","journal-title":"Eur Heart J"},{"issue":"1","key":"5042_CR12","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12959-024-00628-1","volume":"22","author":"Y Wang","year":"2024","unstructured":"Wang Y, Yang Y, Wang L, et al. Antithrombotic therapy at discharge and prognosis in patients with chronic coronary syndrome and atrial fibrillation who underwent PCI: a real-world study [J]. Thromb J. 2024;22(1):65.","journal-title":"Thromb J"},{"issue":"1","key":"5042_CR13","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1186\/s12872-025-04748-y","volume":"25","author":"Y Wang","year":"2025","unstructured":"Wang Y, Zhang H, Tan JS, et al. Complex versus non-complex percutaneous coronary intervention in patients with atrial fibrillation: a real-world study [J]. BMC Cardiovasc Disord. 2025;25(1):285.","journal-title":"BMC Cardiovasc Disord"},{"issue":"2","key":"5042_CR14","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.hjc.2016.05.001","volume":"57","author":"S Foussas","year":"2016","unstructured":"Foussas S. Acute coronary syndromes and atrial fibrillation [J]. Hellenic J Cardiol. 2016;57(2):141\u20132.","journal-title":"Hellenic J Cardiol"},{"issue":"4","key":"5042_CR15","first-page":"142","volume":"12","author":"DS Castiello","year":"2025","unstructured":"Castiello DS, Buongiorno F, Manzi L, et al. Procedural and antithrombotic therapy optimization in patients with atrial fibrillation undergoing percutaneous coronary intervention: a narrative review [J]. J Cardiovasc Dev Dis. 2025;12(4):142.","journal-title":"J Cardiovasc Dev Dis"},{"key":"5042_CR16","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.ijcard.2023.01.007","volume":"377","author":"SC Tang","year":"2023","unstructured":"Tang SC, Liu YB, Lin LY, et al. Association between atrial fibrillation burden and cognitive function in patients with atrial fibrillation [J]. Int J Cardiol. 2023;377:73\u20138.","journal-title":"Int J Cardiol"},{"issue":"6","key":"5042_CR17","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1253\/circj.CJ-16-1054","volume":"81","author":"J Oikawa","year":"2017","unstructured":"Oikawa J, Niwano S, Fukaya H, et al. Novel scoring system for distinction between paroxysmal and non-paroxysmal atrial fibrillation [J]. Circ J. 2017;81(6):788\u201393.","journal-title":"Circ J"},{"issue":"5","key":"5042_CR18","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1161\/CIRCULATIONAHA.115.018614","volume":"133","author":"R Santhanakrishnan","year":"2016","unstructured":"Santhanakrishnan R, Wang N, Larson MG, et al. Atrial fibrillation begets heart failure and vice versa: temporal associations and differences in preserved versus reduced ejection fraction [J]. Circulation. 2016;133(5):484\u201392.","journal-title":"Circulation"},{"issue":"5","key":"5042_CR19","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.hrthm.2021.01.021","volume":"18","author":"BA Steinberg","year":"2021","unstructured":"Steinberg BA, Li Z, O\u2019brien EC, et al. Atrial fibrillation burden and heart failure: data from 39710 individuals with cardiac implanted electronic devices [J]. Heart Rhythm. 2021;18(5):709\u201316.","journal-title":"Heart Rhythm"},{"issue":"10","key":"5042_CR20","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.3390\/ijerph19106173","volume":"19","author":"H Al-Makhamreh","year":"2022","unstructured":"Al-Makhamreh H, Alrabadi N, Haikal L, et al. Paroxysmal and non-paroxysmal atrial fibrillation in middle eastern patients: clinical features and the use of medications analysis of the jordan atrial fibrillation (JoFib) study [J]. Int J Environ Res Public Health. 2022;19(10):1673.","journal-title":"Int J Environ Res Public Health"},{"issue":"4","key":"5042_CR21","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.9638","volume":"6","author":"CP Cannon","year":"2023","unstructured":"Cannon CP, Kim JM, Lee JJ, et al. Patients and their physician\u2019s perspectives about oral anticoagulation in patients with atrial fibrillation not receiving an anticoagulant [J]. JAMA Netw Open. 2023;6(4): e239638.","journal-title":"JAMA Netw Open"},{"issue":"5","key":"5042_CR22","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.jjcc.2022.12.010","volume":"81","author":"H Wada","year":"2023","unstructured":"Wada H, Miyauchi K, Suwa S, et al. Impact of atrial fibrillation type (paroxysmal vs non-paroxysmal) on long-term clinical outcomes: the RAFFINE registry subanalysis [J]. J Cardiol. 2023;81(5):450\u20135.","journal-title":"J Cardiol"},{"issue":"1","key":"5042_CR23","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.hrtlng.2019.07.007","volume":"49","author":"SY Chu","year":"2020","unstructured":"Chu SY, Jiang J, Wang YL, et al. Pacemaker-detected atrial fibrillation burden and risk of ischemic stroke or thromboembolic events-A cohort study [J]. Heart Lung. 2020;49(1):66\u201372.","journal-title":"Heart Lung"},{"issue":"11","key":"5042_CR24","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.1016\/j.jacep.2024.06.020","volume":"10","author":"G Peigh","year":"2024","unstructured":"Peigh G, Koehler J, Majumder S, et al. Associations between changes in maximum daily atrial fibrillation duration, ischemic stroke, and mortality [J]. JACC Clin Electrophysiol. 2024;10(11):2394\u2013406.","journal-title":"JACC Clin Electrophysiol"},{"issue":"20","key":"5042_CR25","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1161\/CIRCULATIONAHA.119.041303","volume":"140","author":"RM Kaplan","year":"2019","unstructured":"Kaplan RM, Koehler J, Ziegler PD, et al. Stroke risk as a function of atrial fibrillation duration and CHA2DS2-VASc score [J]. Circulation. 2019;140(20):1639\u201346.","journal-title":"Circulation"},{"issue":"20","key":"5042_CR26","doi-asserted-by":"publisher","first-page":"e623","DOI":"10.1161\/CIR.0000000000000568","volume":"137","author":"LY Chen","year":"2018","unstructured":"Chen LY, Chung MK, Allen LA, et al. Atrial Fibrillation burden: moving beyond atrial fibrillation as a binary entity: a scientific statement from the American heart association [J]. Circulation. 2018;137(20):e623\u201344.","journal-title":"Circulation"},{"issue":"3","key":"5042_CR27","doi-asserted-by":"publisher","first-page":"euaf019","DOI":"10.1093\/europace\/euaf019","volume":"27","author":"W Doehner","year":"2025","unstructured":"Doehner W, Boriani G, Potpara T, et al. Atrial fibrillation burden in clinical practice, research, and technology development: a clinical consensus statement of the European Society of Cardiology Council on Stroke and the European Heart Rhythm Association [J]. Europace. 2025;27(3):euaf019.","journal-title":"Europace"},{"issue":"20","key":"5042_CR28","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1093\/eurheartj\/ehw007","volume":"37","author":"AN Ganesan","year":"2016","unstructured":"Ganesan AN, Chew DP, Hartshorne T, et al. The impact of atrial fibrillation type on the risk of thromboembolism, mortality, and bleeding: a systematic review and meta-analysis [J]. Eur Heart J. 2016;37(20):1591\u2013602.","journal-title":"Eur Heart J"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-05042-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-025-05042-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-05042-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T11:43:53Z","timestamp":1757331833000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-025-05042-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,2]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5042"],"URL":"https:\/\/doi.org\/10.1186\/s12872-025-05042-7","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,2]]},"assertion":[{"value":"29 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study design and protocol have been approved by the Ethics Committee of Fuwai Hospital and conformed to the Declaration of Helsinki. All the patients had signed informed consents to participate in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"570"}}